Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Pfizer (PFE) stock in plain English

Free brief · no signupStart here
PFEPublished Nov 19, 2026
Pfizer Inc
Healthcare · Drug Manufacturers - General
Discovers, manufactures, and sells prescription medicines, vaccines, and cellular therapies worldwide.
Assets:
35 manufacturing sitesFacilities across North America, Europe, and Asia
88,000 employeesGlobal workforce spanning research, operations, and sales
Seagen oncology unitAdds targeted antibody drug conjugate cancer technology
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

50
OPS ScoreOperating finances
Latest quote
-1.85%$27.54
$156.97B
39.4×
$63.55B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 19, 2026Quotes updated Nov 20, 04:00 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was PFE. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Pfizer (PFE) do?

Pfizer Inc (PFE) is a U.S.-listed company in Healthcare (Drug Manufacturers - General). What it does: Discovers, manufactures, and sells prescription medicines, vaccines, and cellular therapies worldwide. It develops, manufactures, and distributes prescription pharmaceuticals and vaccines through a global commercial supply. It is worth $156.97B on the market and sold $63.55B over the last year.

Market cap
$156.97B
P/E ratio
39.4×
Annual sales
$63.55B
Sector
Healthcare
Industry
Drug Manufacturers - General
Brief updated
Nov 19, 2026

Brands and businesses behind PFE

  • Comirnaty: An mRNA vaccine for COVID-19 that generates sales through government contracts and pharmacy distribution.
  • Eliquis: A blood thinner co-promoted with Bristol Myers Squibb that earns royalties and shared sales revenue.
  • Prevnar: A pneumococcal conjugate vaccine family sold to clinics and healthcare systems for bacterial protection.
  • Paxlovid: An oral antiviral treatment for COVID-19 purchased by health authorities and distributed via prescription.
  • Vyndaqel: A prescription treatment for rare heart and nerve conditions that sells through specialty pharmacies.
  • Ibrance: An oncology medication for metastatic breast cancer sold directly to hospitals and specialized distributors.

PFE’s flags, in plain English

Each flag is a number from Pfizer’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.

Pays You to Hold

Pays a 6.25% dividend a year. The company pays part of its profit to shareholders in cash. A dividend can be cut, so it is not guaranteed.

Wide Gross Margin

Gross margin of 65.1% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Still Climbing

Sales up 8.5% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.

Priced for Perfection

Priced at 39.4 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.

1 more green flag open with the free trial. Try it free for 7 days.

Questions about PFE

How big is Pfizer?

Pfizer’s market cap is $156.97B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $63.55B: what customers paid the company over the last year, before any costs.

What is PFE’s P/E ratio?

PFE’s P/E ratio is 39.4×. Investors pay about 39.4 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with PFE?

Revenues have dropped significantly following the steep post-pandemic decline in demand for Comirnaty and Paxlovid. That is one risk on Pfizer’s card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Pfizer’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. PFE’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card